October 26, 2013 /24-7PressRelease/
-- Darvocet and Darvon pulled from market
Popular painkiller linked to serious heart risk
The U.S. Food and Drug Administration (FDA) has announced that prescription pain medications Darvon and Darvocet are being withdrawn from the U.S. market. The popular painkillers have been linked to serious heart risks that may result in sudden death.
The move comes after the results of an FDA study in which new clinical data shows the drug, which goes by the generic name propoxyphene, puts patients at risk of potentially serious or even fatal heart rhythm abnormalities.
The FDA determined the new data shows the risks of the drug outweigh any benefits.
Darvocet, probably the most recognizable brand-name painkiller in this group, and Darvon are manufactured by Xanodyne Pharmaceuticals, Inc., which has voluntarily agreed to the product withdrawal. The FDA has informed the generic manufacturers of propoxyphene-containing products of Xanodyne's decision to remove its medications from the market and has requested they voluntarily remove their products as well.
The FDA is advising health care professionals to stop prescribing Darvocet, Darvon or generic propoxylene to their patients, and patients who are currently taking the drug should contact their health care professional as soon as possible to discuss switching to another pain medication therapy.
Results of the recent FDA study show that even when taken at recommended doses, propoxyphene causes significant changes to the electrical activity of the heart. These changes can increase the risk for serious abnormal heart rhythms that have been linked to serious adverse effects, including sudden death.
Do you have a Darvocet claim?
If you or a loved one has suffered serious side effects while taking Darvocet, Darvon or generic propoxyphene, you may have a claim against the manufacturer.
Article provided by Panter, Panter & Sampedro, P.A.
Visit us at www.panterlaw.com